SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-22-004061
Filing Date
2022-11-16
Accepted
2022-11-16 07:21:06
Documents
13
Period of Report
2022-11-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K zk2228768.htm   iXBRL 8-K 34621
  Complete submission text file 0001178913-22-004061.txt   217534

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cmmb-20221116.xsd EX-101.SCH 4704
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmmb-20221116_def.xml EX-101.DEF 18332
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmmb-20221116_lab.xml EX-101.LAB 28552
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmmb-20221116_pre.xml EX-101.PRE 20568
7 EXTRACTED XBRL INSTANCE DOCUMENT zk2228768_htm.xml XML 6623
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 221392938
SIC: 2834 Pharmaceutical Preparations